药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cefonicid
Venetoclax
The serum concentration of Ledipasvir can be increased when it is combined with Venetoclax.
Cefonicid
Rolapitant
The serum concentration of Ledipasvir can be increased when it is combined with Rolapitant.
Cefonicid
Niguldipine
The serum concentration of Ledipasvir can be increased when it is combined with Niguldipine.
Cefonicid
Daclatasvir
The serum concentration of Ledipasvir can be increased when it is combined with Daclatasvir.
Cefonicid
Palbociclib
The serum concentration of Ledipasvir can be increased when it is combined with Palbociclib.
Cefonicid
Cobicistat
The serum concentration of Ledipasvir can be increased when it is combined with Cobicistat.
Cefonicid
Netupitant
The serum concentration of Ledipasvir can be increased when it is combined with Netupitant.
Cefonicid
Suvorexant
The serum concentration of Ledipasvir can be increased when it is combined with Suvorexant.
Cefonicid
Vorapaxar
The serum concentration of Ledipasvir can be increased when it is combined with Vorapaxar.
Cefonicid
Brefeldin A
The serum concentration of Ledipasvir can be increased when it is combined with Brefeldin A.
Cefonicid
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Ledipasvir.
Quinethazone
Satralizumab
The serum concentration of Aliskiren can be decreased when it is combined with Satralizumab.
Quinethazone
Abametapir
The serum concentration of Aliskiren can be increased when it is combined with Abametapir.
Quinethazone
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Aliskiren.
Quinethazone
Mebutizide
The therapeutic efficacy of Aliskiren can be increased when used in combination with Mebutizide.
Quinethazone
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be increased when used in combination with Aliskiren.
Quinethazone
Cenobamate
The serum concentration of Aliskiren can be decreased when it is combined with Cenobamate.
Quinethazone
Aripiprazole lauroxil
The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Aliskiren.
Quinethazone
Potassium cation
Potassium cation may increase the hyperkalemic activities of Aliskiren.
Quinethazone
Potassium
Potassium may increase the hyperkalemic activities of Aliskiren.